ResMed revenue and financials

RMD · NYSE · USD

$224.43+1.70%+$3.74

Close · October 7, 2026

In the fiscal year ended June 2026, ResMed reported revenue of $5.65B (+9.85% year over year). Net income was $1.52B, a net margin of 26.9%.

Annual revenue · 2026: $5.65B

Fiscal year ending in June. Sources and method on the page Methodology and sources.

At a glance

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item	FY to Jun 2026	FY to Jun 2025	FY to Jun 2024	FY to Jun 2023	FY to Jun 2022	FY to Jun 2021	FY to Jun 2020	FY to Jun 2019	FY to Jun 2018	FY to Jun 2017
Total assets	8,966	8,174	6,872	6,752	5,096	4,728	4,587	4,108	3,064	3,468
Current assets	4,325	3,506	2,358	2,368	1,931	1,575	1,523	1,145	1,066	1,644
Cash and equivalents	1,469	1,209	238	228	274	295	463	147	189	822
Short-term investments	—	—	—	—	9.2	—	—	—	—	—
Receivables	1,085	991	875	705	602	—	—	—	—	—
Inventory	973	976	994	1,141	851	—	—	—	—	—
Net property, plant and equipment	735	718	699	666	630	—	—	—	—	—
Goodwill	2,910	3,047	2,842	2,770	1,936	1,928	1,890	1,856	1,069	1,065
Other intangible assets	453	465	486	552	346	—	—	—	—	—
Long-term investments	157	140	139	134	49.2	—	—	—	—	—
Current liabilities	1,395	1,019	911	759	689	912	603	556	511	360
Accounts payable	309	278	238	151	159	—	—	—	—	—
Long-term debt	399	658	697	1,431	765	643	1,164	1,259	270	1,079
Total debt	826	852	874	1,580	—	—	—	—	—	—
Total liabilities	2,381	2,207	2,008	2,622	1,735	1,842	2,090	2,035	1,005	1,508
Total equity (incl. minority)	6,585	5,968	4,864	4,130	3,361	—	—	—	—	—
Retained earnings	7,255	6,081	4,992	4,253	3,614	—	—	—	—	—